Jiang JD - Search Results

1

Analgesic Mechanism of Sinomenine against Chronic Pain.

Jiang W, Fan W, Gao T, Li T, Yin Z, Guo H, Wang L, Han Y, Jiang JD. Jiang W, et al. Among authors: jiang jd. Pain Res Manag. 2020 May 6;2020:1876862. doi: 10.1155/2020/1876862. eCollection 2020. Pain Res Manag. 2020. PMID: 32454918 Free PMC article. Review.

2

[CCR5, a new target of anti-HIV drugs].

Han YX, Jiang JD. Han YX, et al. Among authors: jiang jd. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):635-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003. PMID: 14650176 Review. Chinese.

3

Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.

Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS, Chen XH, Wang YL, Li YH, Wu YW, You XF, Zhao LX, Jiang JD. Han YX, et al. Among authors: jiang jd. Antiviral Res. 2005 Dec;68(3):147-53. doi: 10.1016/j.antiviral.2005.09.002. Epub 2005 Oct 25. Antiviral Res. 2005. PMID: 16280177 Clinical Trial.

4

In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.

Yang XY, Li CR, Lou RH, Wang YM, Zhang WX, Chen HZ, Huang QS, Han YX, Jiang JD, You XF. Yang XY, et al. Among authors: jiang jd. J Med Microbiol. 2007 Jan;56(Pt 1):71-76. doi: 10.1099/jmm.0.46788-0. J Med Microbiol. 2007. PMID: 17172520

5

DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast.

Li Y, Liang F, Jiang W, Yu F, Cao R, Ma Q, Dai X, Jiang J, Wang Y, Si S. Li Y, et al. Cancer Biol Ther. 2007 Aug;6(8):1193-9. Epub 2007 May 4. Cancer Biol Ther. 2007. PMID: 17622795

6

Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships.

Song DQ, Wang Y, Wu LZ, Yang P, Wang YM, Gao LM, Li Y, Qu JR, Wang YH, Li YH, Du NN, Han YX, Zhang ZP, Jiang JD. Song DQ, et al. Among authors: jiang jd. J Med Chem. 2008 Jun 12;51(11):3094-103. doi: 10.1021/jm070890u. Epub 2008 May 6. J Med Chem. 2008. PMID: 18457382

7

Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening.

Fu DH, Jiang W, Zheng JT, Zhao GY, Li Y, Yi H, Li ZR, Jiang JD, Yang KQ, Wang Y, Si SY. Fu DH, et al. Among authors: jiang jd, jiang w. Mol Cancer Ther. 2008 Aug;7(8):2386-93. doi: 10.1158/1535-7163.MCT-08-0035. Mol Cancer Ther. 2008. PMID: 18723485

8

DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1.

Zhang J, Li Y, Guo L, Cao R, Zhao P, Jiang W, Ma Q, Yi H, Li Z, Jiang J, Wu J, Wang Y, Si S. Zhang J, et al. Cancer Biol Ther. 2009 Dec;8(24):2374-83. doi: 10.4161/cbt.8.24.10182. Epub 2009 Dec 27. Cancer Biol Ther. 2009. PMID: 19855194

9

Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA.

Peng ZG, Fan B, Du NN, Wang YP, Gao LM, Li YH, Li YH, Liu F, You XF, Han YX, Zhao ZY, Cen S, Li JR, Song DQ, Jiang JD. Peng ZG, et al. Among authors: jiang jd. Hepatology. 2010 Sep;52(3):845-53. doi: 10.1002/hep.23766. Hepatology. 2010. PMID: 20593456

10

Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70.

Gao LM, Han YX, Wang YP, Li YH, Shan YQ, Li X, Peng ZG, Bi CW, Zhang T, Du NN, Jiang JD, Song DQ. Gao LM, et al. Among authors: jiang jd. J Med Chem. 2011 Feb 10;54(3):869-76. doi: 10.1021/jm101325h. Epub 2011 Jan 10. J Med Chem. 2011. PMID: 21218816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page